Quickly place your order in Osiris Therapeutics Inc. This company has synthesized a medicine in collaboration with Genzyme Corp. by the name Prochymal.This drug is made of adult stem cells and is capable of regenerating tissues and preventing scar formation.

Prochymal and a dummy drug were administered to 53 heart-attack patients to experimentally measure and hence compare their efficacy and strength.

Among the 53, 8 patients taking Prochymal experienced a negative event, compared with 11 for patients taking the dummy drug.

This was an early stage trial. It proved that the therapeutic is highly efficient for improving heart functions of patients with weakened hearts or who already have experienced an attack.

Osiris is now planning to study mid-stage and late-stage indications of the drug.

Source:Forbes.com